Drugs target to NQO1

Drug name Drug type Disease/phenotype Mechanism of action(MoA) Phase Status Source
VATIQUINONESmall moleculeLeigh syndromeQuinone reductase 1) modulator2.0CompletedClinicalTrials
VATIQUINONESmall moleculePearson syndromeQuinone reductase 1) modulator2.0TerminatedClinicalTrials
VATIQUINONESmall moleculenoise-induced hearing lossQuinone reductase 1) modulator2.0CompletedClinicalTrials
VATIQUINONESmall moleculeParkinson diseaseQuinone reductase 1) modulator2.0CompletedClinicalTrials
VATIQUINONESmall moleculeTourette syndromeQuinone reductase 1) modulator1.0CompletedClinicalTrials
VATIQUINONESmall moleculeautism spectrum disorderQuinone reductase 1) modulator2.0WithdrawnClinicalTrials
VATIQUINONESmall moleculeFriedreich ataxiaQuinone reductase 1) modulator2.0Active, not recruitingClinicalTrials
VATIQUINONESmall moleculemyopathyQuinone reductase 1) modulator1.0CompletedClinicalTrials
VATIQUINONESmall moleculeRett syndromeQuinone reductase 1) modulator2.0CompletedClinicalTrials
VATIQUINONESmall moleculeFriedreich ataxiaQuinone reductase 1) modulator3.0Not yet recruitingClinicalTrials
VATIQUINONESmall moleculeFriedreich ataxiaQuinone reductase 1) modulator2.0RecruitingClinicalTrials
VATIQUINONESmall moleculemitochondrial diseaseQuinone reductase 1) modulator3.0Enrolling by invitationClinicalTrials
VATIQUINONESmall moleculeFriedreich ataxiaQuinone reductase 1) modulator2.0CompletedClinicalTrials
VATIQUINONESmall moleculeLeigh syndromeQuinone reductase 1) modulator2.0Active, not recruitingClinicalTrials
VATIQUINONESmall moleculemitochondrial diseaseQuinone reductase 1) modulator1.0CompletedClinicalTrials
VATIQUINONESmall moleculemitochondrial diseaseQuinone reductase 1) modulator2.0Active, not recruitingClinicalTrials